FDA Inspection 1286816 — Dendreon Pharmaceuticals LLC

Dendreon Pharmaceuticals LLC — FEI 3008914686

The FDA completed an inspection of Dendreon Pharmaceuticals LLC on Oct 29, 2025 in Union City, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 29, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Union City, GA (United States)

Citations

IDCFRDescription
203121 CFR 211.194(a)Complete test data included in records
358521 CFR 211.110(a)Control procedures to monitor and validate performance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.